Frontlight ResearchEarly access
Antiphospholipid syndrome trials in Italy
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in ItalyPhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Meldola
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - Phase 1Taking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Meldola, Rozzano, Turin
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - Phase 1Enrolling by invitationPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Meldola, Milan, Torino
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - No phaseTaking peoplePatients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
- Where
- Milan
- Age
- 18 years to 45 years
- People
- 60
- Run by
- IRCCS San Raffaele
See details and how to joinNCT05786235 - No phaseTaking peopleNegative Antiphospholipid Syndrome: a Multicentric Study
- Where
- Roma
- Age
- 18 years to 65 years
- People
- 105
- Run by
- Italian Society for Rheumatology
See details and how to joinNCT06373003